FACT-CHECK
Why Seegene and Alteogen Stocks Fell 17%+ as KOSDAQ Slipped 0.8%
Seegene fell 20.81% after its Q3 earnings disclosure. Alteogen fell 16.81% on reports of U.S. drug price pressure, with no company filing.
Every time Seegene (096530) moved sharply, checked against filings and numbers. 1 article(s), newest first.
Seegene fell 20.81% after its Q3 earnings disclosure. Alteogen fell 16.81% on reports of U.S. drug price pressure, with no company filing.